Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Oliver Rider

BA (hons), BMBCh (hons), FRCP (UK), DPhil (Oxon)


Professor of Cardiovascular Medicine

  • British Heart Foundation Senior Clinical Research Fellow
  • Deputy Clinical Director of OCMR
  • Honorary Consultant Cardiologist

After studying medicine at Pembroke College (1996-2002) I completed the Royal College Examinations and specialized in Cardiology. In 2005 I was awarded a Wellcome Trust Junior Research Fellowship to complete my DPhil in Cardiovascular medicine at Oxford, where I used advanced cardiac magnetic resonance imaging and spectroscopy to study the effects of obesity and weight loss on myocardial metabolism and function. For this work I was awarded the American Heart Association Young Investigator Award for Nutrition Physical Activity and Metabolism (2008) and took up the role of Clinical Lecturer in Cardiovascular Medicine in Oxford in 2010 where I furthered my research into obesity. In 2015 I was appointed as an Honorary Consultant Cardiologist and Deputy Clinical Director or the University of Oxford Centre for Clinical Magnetic Resonance Research.  I held a British Heart Foundation Intermediate Clinical Research Fellowship between 2016 and 2022 and was awarded the BHF/BCS Michael Davies Early Career Award in 2019, and followed this with a British Heart Foundation Senior Clinical Research Fellowship award in 2022. I now run a research group that uses advanced cardiac magnetic resonance imaging and spectroscopy to investigate the relationship between cardiac substrate metabolism, cardiac energetics and cardiac function in multiple diseases with a focus on cardiometabolic heart disease and heart failure.